George P. Tegos

11.0k total citations · 3 hit papers
78 papers, 8.4k citations indexed

About

George P. Tegos is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, George P. Tegos has authored 78 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 26 papers in Molecular Biology and 26 papers in Biomedical Engineering. Recurrent topics in George P. Tegos's work include Photodynamic Therapy Research Studies (30 papers), Nanoplatforms for cancer theranostics (25 papers) and Antifungal resistance and susceptibility (12 papers). George P. Tegos is often cited by papers focused on Photodynamic Therapy Research Studies (30 papers), Nanoplatforms for cancer theranostics (25 papers) and Antifungal resistance and susceptibility (12 papers). George P. Tegos collaborates with scholars based in United States, Greece and Brazil. George P. Tegos's co-authors include Michael R. Hamblin, Tianhong Dai, Kim Lewis, Frank R. Stermitz, Asheesh Gupta, Eleftherios Mylonakis, Olga Lomovskaya, Rui Yin, Santi Nonell and Martha S. Ribeiro and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.

In The Last Decade

George P. Tegos

78 papers receiving 8.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond

2013 868 citations Fatma Vatansever, Wanessa C. M. A. Melo et al. FEMS Microbiology Reviews profile →
The value of antimicrobial peptides in the age of resistance

2020 806 citations Maria Magana, Ana L. Santos et al. profile →
Photoantimicrobials—are we afraid of the light?

2016 553 citations Mark Wainwright, Santi Nonell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George P. Tegos United States	48	3.0k	2.9k	2.3k	1.4k	986	78	8.4k
Tim Maisch Germany	44	4.1k 1.4×	3.5k 1.2×	1.2k 0.5×	1.4k 1.0×	203 0.2×	103	7.5k
Marlus Chorilli Brazil	51	877 0.3×	2.0k 0.7×	2.6k 1.1×	1.2k 0.9×	474 0.5×	413	10.6k
Hyun Koo United States	71	791 0.3×	3.2k 1.1×	6.4k 2.8×	1.8k 1.2×	1.6k 1.6×	189	18.5k
Hans E. Junginger Netherlands	76	1.2k 0.4×	1.1k 0.4×	4.7k 2.0×	879 0.6×	351 0.4×	233	17.6k
Claus Moser Denmark	48	1.7k 0.6×	873 0.3×	6.4k 2.8×	372 0.3×	1.7k 1.7×	215	11.7k
Oana Ciofu Denmark	52	3.0k 1.0×	1.0k 0.3×	8.1k 3.5×	514 0.4×	1.9k 2.0×	122	12.8k
Peter Østrup Jensen Denmark	56	2.1k 0.7×	1.0k 0.3×	8.2k 3.6×	444 0.3×	2.0k 2.0×	167	12.9k
Mariana Henriques Portugal	51	528 0.2×	969 0.3×	2.7k 1.2×	1.1k 0.8×	1.0k 1.0×	233	10.3k
Jean‐Yves Maillard United Kingdom	47	619 0.2×	573 0.2×	2.1k 0.9×	594 0.4×	976 1.0×	154	7.1k
Simon Swift New Zealand	42	522 0.2×	996 0.3×	5.0k 2.2×	296 0.2×	789 0.8×	187	9.1k

Countries citing papers authored by George P. Tegos

Since Specialization

Citations

This map shows the geographic impact of George P. Tegos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George P. Tegos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George P. Tegos more than expected).

Fields of papers citing papers by George P. Tegos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George P. Tegos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George P. Tegos. The network helps show where George P. Tegos may publish in the future.

Co-authorship network of co-authors of George P. Tegos

This figure shows the co-authorship network connecting the top 25 collaborators of George P. Tegos. A scholar is included among the top collaborators of George P. Tegos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George P. Tegos. George P. Tegos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santos, Ana L., Jacob L. Beckham, Dongdong Liu, et al.. (2023). Visible‐Light‐Activated Molecular Machines Kill Fungi by Necrosis Following Mitochondrial Dysfunction and Calcium Overload. Advanced Science. 10(10). e2205781–e2205781. 13 indexed citations

Santos, Ana L., Dongdong Liu, John T. Li, et al.. (2022). Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane. Science Advances. 8(22). eabm2055–eabm2055. 57 indexed citations

Rivas, Ariel L., Stephen D. Smith, Almira L. Hoogesteijn, et al.. (2020). Early network properties of the COVID-19 pandemic – The Chinese scenario. International Journal of Infectious Diseases. 96. 519–523. 7 indexed citations

Sabino, Caetano P., Anthony R. Ball, Maurı́cio S. Baptista, et al.. (2020). Light-based technologies for management of COVID-19 pandemic crisis. Journal of Photochemistry and Photobiology B Biology. 212. 111999–111999. 62 indexed citations

Rineh, Ardeshir, John B. Bremner, Michael R. Hamblin, et al.. (2018). Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivo. Bioorganic & Medicinal Chemistry Letters. 28(16). 2736–2740. 26 indexed citations

Tegou, E., Maria Magana, Anastasios Ioannidis, et al.. (2016). Terms of endearment: Bacteria meet graphene nanosurfaces. Biomaterials. 89. 38–55. 60 indexed citations

Fair, Jeanne M., Stylianos Chatzipanagiotou, Anastasios Ioannidis, et al.. (2016). Preventing Data Ambiguity in Infectious Diseases with Four-Dimensional and Personalized Evaluations. PLoS ONE. 11(7). e0159001–e0159001. 7 indexed citations

Ioannidis, Anastasios, Maria Magana, Cristian Bologa, et al.. (2015). Defining the microbial effluxome in the content of the host-microbiome interaction. Frontiers in Pharmacology. 6. 31–31. 3 indexed citations

Agrawal, Tanupriya, Pinar Avci, Gaurav Gupta, et al.. (2015). Harnessing the Power of Light to Treat Staphylococcal Infections Focusing on MRSA. Current Pharmaceutical Design. 21(16). 2109–2121. 11 indexed citations

10.

Rineh, Ardeshir, Michael J. Kelso, Fatma Vatansever, George P. Tegos, & Michael R. Hamblin. (2014). Clostridium difficileinfection: molecular pathogenesis and novel therapeutics. Expert Review of Anti-infective Therapy. 12(1). 131–150. 79 indexed citations

11.

Strouse, J. Jacob, Irena Ivnitski‐Steele, Anna Waller, et al.. (2013). Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters. Analytical Biochemistry. 437(1). 77–87. 50 indexed citations

12.

Vatansever, Fatma, Wanessa C. M. A. Melo, Pinar Avci, et al.. (2013). Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiology Reviews. 37(6). 955–989. 868 indexed citations breakdown →

13.

Ball, Anthony R., Ying‐Ying Huang, Sanjay M. Jachak, et al.. (2013). Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation. The Open Microbiology Journal. 7(1). 34–52. 114 indexed citations

14.

Dai, Tianhong, Clinton K. Murray, Mark S. Vrahas, et al.. (2012). Ultraviolet C light for Acinetobacter baumannii wound infections in mice. The Journal of Trauma: Injury, Infection, and Critical Care. 73(3). 661–667. 27 indexed citations

15.

Dai, Tianhong, Beth Burgwyn Fuchs, Jeffrey J. Coleman, et al.. (2012). Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform. Frontiers in Microbiology. 3. 120–120. 225 indexed citations

16.

Prates, Renato Araújo, Michael R. Hamblin, Ilka Tiemy Kato, et al.. (2011). Cryptococcus neoformans capsule protects cell from oxygen reactive species generated by antimicrobial photodynamic inactivation. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7887. 788709–788709. 2 indexed citations

17.

Tegos, George P., Mark K. Haynes, J. Jacob Strouse, et al.. (2011). Microbial Efflux Pump Inhibition: Tactics and Strategies. Current Pharmaceutical Design. 17(13). 1291–1302. 111 indexed citations

18.

Ragàs, Xavier, Tianhong Dai, George P. Tegos, et al.. (2010). Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: In vitro and in vivo studies. Lasers in Surgery and Medicine. 42(5). 384–390. 95 indexed citations

19.

Tegos, George P., et al.. (2008). Inhibitors of Bacterial Multidrug Efflux Pumps Potentiate Antimicrobial Photoinactivation. Antimicrobial Agents and Chemotherapy. 52(9). 3202–3209. 108 indexed citations

20.

Mróz, Paweł, George P. Tegos, Hariprasad Gali, et al.. (2007). Photodynamic therapy with fullerenes. Photochemical & Photobiological Sciences. 6(11). 1139–1149. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact